11 Papers
10 Citations
Piao Li is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
FGFR2 Promotes Expression of PD-L1 in Colorectal Cancer via the JAK/STAT3 Signaling Pathway.
TL;DR: A novel mechanism of PD-L1 expression in CRC is revealed, thus providing a theoretical basis for reversing the immune tolerance of FGFR2 overexpression in CRC.
169
FGF7/FGFR2 signal promotes invasion and migration in human gastric cancer through upregulation of thrombospondin-1
Tingting Huang,Lei Wang,Dian Liu,Piao Li,Huihua Xiong,Liang Zhuang,Li Sun,Xianglin Yuan,Hong Qiu +8 more
TL;DR: The data suggest that FGF7/FGFR2/THBS1 is associated with the regulation of invasion and migration in human gastric cancer.
FGFR2 Promotes Gastric Cancer Progression by Inhibiting the Expression of Thrombospondin4 via PI3K-Akt-Mtor Pathway.
Tingting Huang,Dian Liu,Yihua Wang,Yihua Wang,Piao Li,Li Sun,Huihua Xiong,Yuhong Dai,Man Zou,Xianglin Yuan,Hong Qiu +10 more
TL;DR: The FGFR2 signal promotes human GC progression through the downregulation of TSP4 via PI3K-AKT-mTOR pathway and is correlated with a high risk of lymph node metastasis, late clinical stage, and poor prognosis.
FERMT1 contributes to the migration and invasion of nasopharyngeal carcinoma through epithelial–mesenchymal transition and cell cycle arrest
TL;DR: In this article , the role of Fermitin family member 1 (FERMT1) in the development of nasopharyngeal carcinoma (NPC) was investigated.
Sitagliptin Alleviates Radiation-Induced Intestinal Injury by Activating NRF2-Antioxidant Axis, Mitigating NLRP3 Inf--lammasome Activation, and Reversing Gut Microbiota Disorder
Shanshan Huang,Yongbiao Huang,Wan-Syuan Lin,Lei Wang,Yang Yang,Piao Li,Lei Xiao,Yuanwen Chen,Qian Chu,Xianglin Yuan +9 more
TL;DR: It is suggested that Sitagliptin could reduce WAI-induced intestine injury in mice, which may provide novel therapeutic strategy for radiation-induced intestinal injury.